| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 100,855 | 90,110 | 96,145 | 135,264 | | Cost of Revenue | 48,665 | 43,339 | 43,217 | 59,117 | | | Gross Profit | 52,190 | 46,771 | 52,928 | 76,147 | | | Operating Expenses | | Research Development | 27,128 | 27,799 | 29,309 | 34,280 | | Selling General and Administrative | 34,838 | 33,561 | 33,222 | 35,895 | | Non Recurring | 2,206 | 3,532 | 6,428 | 116,753 | | Others | 3,078 | 5,482 | 6,941 | 5,415 | | | | Total Operating Expenses | 67,250 | 70,374 | 75,900 | 192,343 | | | | Operating Income or Loss | (15,060) | (23,603) | (22,972) | (116,196) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,185 | 2,151 | 79,363 | (865) | | Earnings Before Interest And Taxes | (13,875) | (21,452) | 56,391 | (117,061) | | Interest Expense |
-
| (477) | 477 | (545) | | Income Before Tax | (13,875) | (20,975) | 55,914 | (116,516) | | Income Tax Expense | (1,706) | (7,666) | 29,200 | (12,003) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,169) | (13,309) | 26,714 | (104,513) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,169) | (13,309) | 26,714 | (104,513) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,169) | ($13,309) | $26,714 | ($104,513) |
|
0.31% Nasdaq 0.00%
Income Statement
